Prostate cancer in patients with an abnormal digital rectal examination and serum prostate-specific antigen less than 4.0 ng/mL
Authors:
- Caleb B. BozemanCBCaleb B. Bozeman
- Brett S. CarverBCBrett S. Carver
- Gloria CalditoGCGloria Caldito
- Dennis D. VenableDVDennis D. Venable
- James A. EasthamJEJames A. Eastham
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Serendipity in detecting disease in low prostate‐specific antigen rangesBJU International, 2002
- PROSTATE CANCER DETECTION IN BLACK AND WHITE MEN WITH ABNORMAL DIGITAL RECTAL EXAMINATION AND PROSTATE SPECIFIC ANTIGEN LESS THAN 4 NG./ML.Journal of Urology, 2000
- PROSTATE CANCER DETECTION AT LOW PROSTATE SPECIFIC ANTIGENJournal of Urology, 2000
- Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mLUrology, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI: Journal of the National Cancer Institute, 1999
- DIGITAL RECTAL EXAMINATION FOR DETECTING PROSTATE CANCER AT PROSTATE SPECIFIC ANTIGEN LEVELS OF 4 NG./ML. OR LESSJournal of Urology, 1999
- Interexaminer variability of digital rectal examination in detecting prostate cancerUrology, 1995
- Diagnosis of Prostatic Carcinoma: The Yield of Serum Prostate Specific Antigen, Digital Rectal Examination and Transrectal UltrasonographyJournal of Urology, 1994
- Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 MenJournal of Urology, 1994
- Prostate Cancer Detection in a Clinical Urological Practice by Ultrasonography, Digital Rectal Examination and Prostate Specific AntigenJournal of Urology, 1990